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ABSTRACT 
Objectives: Iodine deficiency (ID) is a common cause of preventable brain damage and mental retardation worldwide, 
according to the World Health Organisation. It may adversely affect brain maturation processes that potentially result in 
structural and metabolic brain abnormalities, visible on Magnetic Resonance (MR) techniques. Currently, however, 
there has been no review of the appearance of these brain changes on MR methods. Methods: A systematic review was 
conducted using 3 online search databases (Medline, Embase and Web of Knowledge) using multiple combinations of 
the following search terms: iodine, iodine deficiency, magnetic resonance, MRI, MRS, brain, imaging and iodine defi-
ciency disorders (i.e. hypothyroxinaemia, congenital hypothyroidism, hypothyroidism and cretinism). Results: Up to 
May 2013, 1673 related papers were found. Of these, 29 studies confirmed their findings directly using MR Imaging 
and/or MR Spectroscopy. Of them, 28 were in humans and involved 157 subjects, 46 of whom had primary hypothy-
roidism, 97 had congenital hypothyroidism, 3 had endemic cretinism and 11 had subclinical hypothyroidism. The stud-
ies were small, with a mean relevant sample size of 6, median 2, range 1 - 35, while 14 studies were individual case 
reports. T1-weighted was the most commonly used MRI sequence (20/29 studies) and 1.5 Tesla was the most com-
monly used magnet strength (6/10 studies that provided this information). Pituitary abnormalities (18/29 studies) and 
cerebellar atrophy (3/29 studies) were the most prevalent brain abnormalities found. Only fMRI studies (3/29) reported 
cognition-related abnormalities but the brain changes found were limited to a visual description in all studies. Conclu-
sions: More studies that use MR methods to identify changes on brain volume or other global structural abnormalities 
and explain the mechanism of ID causing thyroid dysfunction and hence cognitive damage are required. Given the role 
of MR techniques in cognitive studies, this review provides a starting point for researching the macroscopic structural 
brain changes caused by ID. 
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1. Introduction 
Iodine is an important micronutrient and a fundamental 
substrate for the synthesis of thyroid hormones [1,2]. Tri- 
iodothyronine (T3) and thyroxine (T4) are examples of 
iodinated thyroid hormones essential for several cellular 
metabolic processes and the development of the central 
nervous system [3]. Thyroid hormone functions are im-
paired by iodine deficiency [4], reflected as increased  
plasma thyroid stimulating hormone (TSH) and plasma 
T3 concentrations with reduced tissue and plasma T4 
levels [5]. 
Iodine deficiency (ID) is one of the three key micro-
nutrient deficiencies highlighted as major public health 
issues by the World Health Organisation: in 1990, 1.6 
billion people, or 28.9% of the global population, were at 
risk and it was thus considered a serious public health 
issue throughout the world [6-8]. In 2011 this figure had 
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risen to 2 billion and, after starvation, ID is currently the 
single greatest cause of preventable mental retardation 
and brain damage [9]. European countries are usually 
assumed to be iodine sufficient, however, several pockets 
of insufficiency have been described (including UK, Italy, 
Belgium), with no official data available for several 
countries.  
The degree of neurological impairment and the likeli-
hood of its permanence are not only related to the sever-
ity of ID but also to the stage of life at which the indi-
vidual is exposed to it [10]. Iodine deficiency disorders, 
such as hypothyroidism, may reflect a maternal, fetal or 
neonatal childhood thyroid hormone insufficiency [11]. 
At differing time-points, thyroid hormones have particu-
lar effects on brain maturation, regulation of neuronal 
development and microglial proliferation [12], dendritic 
arborisation, synaptogenesis, cell migration and myelina-
tion [11]. Fetal’s thyroid hormones rely on iodine sup-
plemented from the maternal circulation so as to ensure 
adequate mental development [13]. Iodine insufficiency 
in fetal life and early childhood is associated with de-
creased IQ even in the absence of manifest hypothyroid-
ism [14]. Many studies in areas of mild iodine deficiency 
have shown a range of developmental impairments in-
cluding poor visual-motor performance and motor skills, 
decreased neuromotor and perceptual ability and lower 
developmental and intelligence quotients [7]. There is 
clearly an association between sub-optimal intellectual 
performance and iodine deficiency including maternal 
iodine deficiency during pregnancy [7,14-18]. 
Despite recommendations to increase daily iodine in-
take from 150 µg/day to 250 µg/day during pregnancy, 
up to 40% of pregnant women in Scotland have been 
shown to be at risk of iodine deficiency [19]. Although 
few people have frank iodine deficiency and diet-driven 
hypothyroidism, a low or marginal intake will present a 
potential hazard in pregnancy, when demand is increased 
[20]. Iodine is obtained mainly through the diet. The io-
dine content of food and water is dependent on a variety 
of factors: including geographical location, mineral con-
tent of the soil, bacteria, rainfall, altitude and fertilisers 
used [21] as well as longstanding fortification pro-
grammes with iodine-supplemented salt introduced to 
counteract dietary deficiency [22,23]. There is no ongo-
ing iodine-fortification programme in the UK [24]. Main 
sources of iodine in the British diet are milk and dairy 
products, and fish and seafood [25]. It is likely that a 
substantial proportion of the young female population 
excludes at least one of these food groups from their di-
ets, leading to either low or marginal iodine intake [16]. 
Meanwhile, fast-food meals and pre-cooked dishes do 
not ensure that the minimum iodine requirement is ful-
filled: 150 - 300 µg I per day [26]. The most recent sur-
vey conducted in the UK revealed a median urinary io-
dine excretion (i.e. marker of ID at population level) of 
80 μg/L, indicative of mild deficiency (50 - 99 μg/L) [9]. 
The brain is particularly sensitive to the adverse ef-
fects of ID since neural development occurs at a critical 
period, prior to the rest of the body [27]. This is reflected 
in the disproportionate weight of the brain in a neonate, 
representing 10% of total body mass, compared to 2% in 
a fully grown adult [27]. Animal models of ID have pro-
vided evidence of changes to the morphology and cy-
toarchitecture of the brain. In sheep models of ID, re-
duced brain DNA and brain weight with delayed cere-
bellar maturation were identified [28-30]. In rat brains 
studies have reported altered metabolic activity and 
laminar volumes in the hippocampus and dentate gyrus 
[31] and altered tissue distribution of other trace ele-
ments [32-34]. It is also suggested that certain brain pro-
teins may be down-regulated in particular brain regions 
[35], anterior commissure axons and mRNA expression 
may be reduced [36,37], dendrite size may be altered [38] 
and premature cell apoptosis may result [39]. Addition-
ally, ID may cause a reduction in cerebellar cell size and 
decreased myelination throughout the Central Nervous 
System [40].  
Magnetic Resonance (MR) is a powerful, non-invasive 
tool for detecting and quantifying structural and meta-
bolic brain changes in life over time. Although access is 
limited in some regions, it is increasingly available 
throughout the world. Despite the strong link between 
iodine insufficiency and neurodevelopment and impaired 
cognition, brain structural changes have rarely been in-
vestigated in the context of iodine insufficiency. We hy-
pothesise that insufficient dietary iodine intake or aber-
rant iodine metabolism results in structural and metabolic 
neurological changes in the brain that can be assessed by 
MR methods. Currently, few reports exist regarding the 
appearance of these changes on MR. Studies in ID dis-
orders report histological, psychological, physical and 
behavioural changes but use no brain MR confirmation 
and brain changes are often inconsistently described. 
This systematic review was necessary to clarify reported 
changes on brain MR.  
2. Aims and Hypothesis 
2.1. Aims 
This review aims to identify what brain structural and 
metabolic abnormalities related to ID are documented 
using Magnetic Resonance Imaging (MRI) and other MR 
techniques such as Magnetic Resonance Spectroscopy 
(MRS). 
2.2. Hypothesis 
The hypothesis of this review is that insufficient dietary 
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iodine content or aberrant iodine metabolism results in 
structural and metabolic neurological changes in the 
brain, detectable on MR methods. 
3. Methods 
3.1. Search Criteria 
Primary research studies, published in full and using MR 
techniques to determine brain region modifications, were 
identified in a literature search. A combination of case 
reports, prospective and retrospective studies were re-
viewed. The electronic search was conducted up to May 
2013 using the following databases: Medline©, Web of 
Knowledge© and Embase©. It was supplemented by 
hand-searching reference lists of the review papers and 
by request to the corresponding authors of identified pa-
pers not openly accessible. Multiple combinations of the 
following search terms were used: iodine, iodine defi-
ciency, iodine deposits, magnetic resonance imaging/ 
MRI, brain, imaging, hypothyroxinaemia, congenital 
hypothyroidism, hypothyroidism and cretinism. The lat-
ter four search terms were proposed as they may be con-
sidered as iodine deficiency disorders. Maternal hypo-
thyroxinaemia may result from inadequate iodine intake 
[41-44] and may cause neurodevelopmental defects. 
Neonatal hypothyroxinaemia, from postnatal reductions 
in T4 concentration, but with normal TSH, may occur 
due to in utero iodine insufficiencies [45,46]. Congenital 
hypothyroidism, caused by maternal and thence fetal 
hypothyroidism, may, therefore, also result from iodine 
deficiency, with an incidence of 1:3000 to 1:4000 live 
births [47,48]. One of the worst consequences of ID and 
a more severe form of hypothyroidism is endemic cretin-
ism, a condition characterised by neurological deficits, 
deaf-mutism and spasticity [49-51] that occurs where ID 
is common in the community.  
One reviewer independently carried out the primary 
literature search, paper selection, duplicate removal and 
data extraction up to March 2012 and other reviewer ex-
tended the search up to May 2013. Three different re-
viewers assessed a sample of papers for inclusion and 
helped extract the relevant data on each occasion. Al-
though papers may have passed eligibility checks ac-
cording to the inclusion/exclusion criteria listed below, 
full texts were read prior to final rejection of studies. 
3.2. Inclusion Criteria 
Studies were included which used MR methods to iden-
tify brain structural and/or metabolic changes in the brain 
associated with ID or ID disorders. Inclusion criteria also 
comprised studies available in English only. Both human 
and animal studies were included as well as studies from 
healthy or diseased brains. 
3.3. Exclusion Criteria 
Studies were excluded if they did not meet the inclusion 
criteria or were published only as abstracts without full 
publication available. Studies in which iodine was used 
therapeutically or as a drug treatment were rejected and 
studies which involved the injection of radioactive iodine 
used as a contrast agent for visualising a specific pathol-
ogy (e.g. thyroid carcinoma) were also excluded. Studies 
in which hypothyroidism was induced by thyroidectomy 
or was due to other non-iodine related causes (such as 
autosomal, goitrogen, steroid consumption, following 
head trauma, caused by Hashimoto’s thyroiditis, stress or 
autoimmune aetiology) were rejected. Studies on cancer 
patients or those in which the MR method did not in-
volve studying or imaging the brain (e.g. thyroid scinti-
graphy) were also rejected. The literature search pro-
duced many papers which involved non relevant subject 
areas and/or diseases; diabetes mellitus, multiple sclero-
sis, epilepsy, Parkinson’s, Alzheimer’s, bipolar disorder 
and Turner’s syndrome are examples which were ex-
cluded as the non-iodine related consequences of these 
diseases may affect the appearance of brain changes. 
Reviews which discuss MR changes associated with io-
dine deficiency were excluded from the data analysis 
unless they included new data that was not published 
elsewhere. If the cause of the disorder (e.g. hypothyroid-
ism) was not ID or not stated the study was rejected. 
3.4. Data Extraction 
For each study that was included: the type of MR con-
firmation, the appearance on MR method, the location of 
the abnormality, the pathology/disease studied and the 
sample size (i.e. number of subjects) was independently 
extracted. Often the particular type of MR technique used 
was not discussed in the body of the text and so the rele-
vant information was extracted from MR image descrip-
tions. Additionally, information related to subject pa-
thology was sometimes acquired from tables. 
3.5. Data Analysis  
The techniques used to identify structural and/or meta- 
bolic brain changes were quantified, including: 
Number of subjects included in the studies 
 How many studies successfully used MR techniques 
to determine brain changes  
 How many studies that  used MR methods reported 
discrepancies on the brain changes 
 Whether the studies included blinding, randomisation 
or an inclusion/exclusion criteria 
Moreover, two further questions were posed: 
 Where are the most common locations of the brain 
changes? 
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 What diseases/pathologies discussed in the studies 
were associated with which brain changes/ MR ab-
normality appearances? 
However, these last two questions are not the main 
focus of this review since results only encompass studies 
which used MR confirmation, rather than all of the lit-
erature that discusses the relationship between iodine 
deficiency and the brain. 
Figure 1). 1155 papers were rejected because the paper 
involved non-relevant diseases [Exclusion Criteria], was 
not related to the effects of ID on the brain and/or used 
iodine as a contrast medium or therapy, the full paper 
was not written in English (i.e. no translation was avail-
able for 330 papers) or was not attainable through the 
search databases. Further 60 duplicate papers were re-
jected. Of the remaining 128, 46 review articles and 47 
that did not confirm findings using MR techniques (i.e. 
used CT, Nuclear Medicine methods and/or ultrasound) 
or those in which the MR technique was not applied to 
the brain, such as thyroid or whole body scintigraphy, 
were excluded from the data analysis. Finally, six studies 
on hypothyroidism that did not specify the cause [Exclu- 
4. Results 
The literature search identified 1673 publications; 553 
from Medline, 625 from Web of Knowledge, 490 from 
Embase and 5 from review paper reference lists. 29 of 
these studies were included in the review (Table 1 and  
 
 
Figure 1. Flow chart summarising the spectrum of results from the literature search. 
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Table 1. Summary of included studies (Agrawal 2011 to Zhu 2006). 
Reference Pathology studied 
Sample 
type 
Relevant  
Sample size* 
MR  
method 
MR sequence 
/modality 
Finding/appearance  
on MR 
Abnormality 
location 
Magnetic 
field 
strength 
Agrawal 201166 PH Human 1 MRI T1W + T2W Enlargement Pituitary / 
Aijing 201052 PH Human 8 MRI / Enlargement Pituitary / 
Akinci 200667 CH Human 8 MRS + MRI T1W +T2W Decreased NAA/Cr ratios PWM +  Thalamus 1.5T 
Alves 198968 CH Human 1 MRI T2W (spin echo and inversion recovery)
Patchy hyperintensities  
in white matter 
Splenium and 
Frontal lobe 0.5T 
Ashley 200553 PH Human 1 MRI T1W Enlargement Pituitary / 
Atchison 198965 PH Human 3 MRI /(images show T1W seq) Enlargement 
Pituitary  
(sellar and 
suprasellar) 
/ 
Blasi 200969 CH Human 15 fMRI + MRI T1W + T2W 
Decreased sup. + inf. parietal 
cortex activation; increased 
SMA, precentral gyrus, 
insula + L somatosensory 
parietal cortex activation 
Parietal cortex, 
SMA, 
precentral 
gyrus, insula 
1.5T 
Dedov 199454 PH Human 10 MRI Spin-echo Empty sella turcica  (on 6/10 subjects) Pituitary 0.234T 
Desai 199670 CH Human 10 MRI 
T1W + T2 * W 
(gradient echo) on 
selected patients 
Enlargement Pituitary 0.2T 
Dutta 201264 PH Human 1 MRI T1W Empty sella turcica Pituitary / 
Ehirim 199855 PH Human 1 MRI T1W Enlargement Pituitary / 
Garcia-Centeno 
201056 PH Human 13 MRI T1W Empty sella turcica Pituitary 1.5T 
Goswami 199957 PH Human 1 MRI T1W Enlargement Pituitary / 
Graber 200971 CH Human 1 MRI T1W Hypoplasia Cerebellar vermis / 
Gupta 200572 CH Human 5 
MRS + 
 
MRI 
STEM, 
 
T1W + T2W 
Increased Cho/Cr ratio 
Mild cerebral cortical  
atrophy in frontal  
and parietal lobes 
/ 2T 
Hasegawa 201080 PerH Rat 8 MRI / 
Reduced total brain volume 
but ratio of hippocampal 
volume to total brain volume 
remains constant 
Brain as a 
whole 7T 
Kroese 200458 PH Human 1 MRI / Enlargement Pituitary / 
Lee 200859 PH Human 1 MRI T1W + T2W Enlargement Pituitary / 
Mauceri 199773 CH Human 1 MRI T2W Hypoplasia 
R. cerebellar 
vermis &  
hemisphere 
/ 
Fujiwara 200874 CH Human 6 MRI / 
Decreased anterior pituitary, 
ectopic posterior pituitary 
(on 4/6 subjects) 
Pituitary / 
Passeri 201160 PH Human 1 MRI T1W Enlargement Pituitary / 
Sengupta 201263 PH Human 1 MRI T1W Enlargement (hyperplasia) Pituitary / 
Shogan 201061 PH Human 1 MRI T1W Sella turcica expansion with pituitary enlargement Pituitary / 
Tai 199378 EC Human 3 MRI T1W + T2W Altered intensity 
Globus Pallidus 
+ Substantia 
Nigra 
/ 
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Continued 
Tajima 200775 CH Human 1 MRI / Atrophy Cerebellum / 
Wheeler 201176 CH Human 35 MRI T1W + T2W Decreased L.  hippocampal size Hippocampus 1.5T 
Wheeler 201277 CH Human 14 fMRI T1W Increased bilateral activation Hippocampus 1.5T 
Young 199962 PH Human 2 MRI / Enlargement Pituitary / 
Zhu 200679 SH Human 11 fMRI + MRI T1W + T2W Decreased activation IFG,  DLPFC + SMA 1.5T 
 
sion Criteria] were excluded from the main data analysis 
and discussed separately. 
 
4.1. Sample Size 
In total, 165 subjects were included from the 29 studies. 
Of these, 46 subjects were in studies on primary hypo- 
thyroidism [52-66] (i.e. in which hypothyroidism was 
related to ID), 97 subjects in studies on congenital hy- 
pothyroidism [67-77], 3 subjects in a study of endemic 
cretinism [78], 11 subjects in a study of subclinical hy- 
pothyroidism [79,80] and 8 subjects in a study of perina- 
tal hypothyroidism [80] (Figure 2). One study used ani- 
mals [80], involving 8 congenital hypothyroid and 8 con- 
trol rats aged between 7 and 11 months old, yet there was 
no reporting of death numbers or inclusion/exclusion 
criteria. The mean sample size (for subjects included in 
all studies) was 6, the median was 2 and the range 1 - 35, 
but 14 studies were single case reports [53,55,57-61,63, 
64,66,68,71,73,75]. The age range of the human subjects 
was 0 - 50 years. The study with the largest number of 
included subjects was from Wheeler et al. (2011) [76], 
with 35 congenital hypothyroid patients. 
Figure 2. Number of subjects on each pathology included. 
 
disorders, risk factors for brain injury (e.g. hypoxia, 
teratogens), central nervous system disorders, head 
trauma, prematurity, congenital malformations or a psy-
chiatric disorder. 
4.3. Type of MR Confirmation 
The most commonly used imaging method was structural 
MRI (29/29 studies) (Tables 1 and 3), predominantly 
with conventional structural sequences. MRS was used in 
2 studies [67,72] and functional MRI (fMRI) in 3 studies 
[69,77,79]. T1-weighted (T1W) was the sequence most 
widely used (in 20/29 studies). T2-weighted (T2W) se- 
quence was utilised in 11/29 studies whilst 6/29 studies 
did not clarify the MRI sequence used. In 2 studies, only 
60% of the hypothyroid patients showed brain changes 
on MRI [54,74] (Table 3).  
4.2. Blinding, Randomisation and  
Inclusion/Exclusion Criteria 
The quality of the data presented by this study was as- 
sessed following the PRISMA statement [81] and a 
modification of the QUADAS tool [82]. Results are 
shown in Table 2. Two studies used blinding of asses- 
sors to iodine status [69,76], and the image processing on 
other study [77] was done fully automatically. Although 
the data processing in all fMRI studies was also done 
fully automatically, there was no evidence of blindness in 
the imaging data acquisition. Randomisation was only 
provided in the animal study whereby rats were ran- 
domly assorted into control and treatment groups for 
MRI experimentation [80]. Ten studies gave implicit 
inclusion/exclusion criteria through the description of the 
characteristics of the sample and five gave them explic- 
itly [67,69,74,76,77]. Reasons for rejection were patients 
with unrelated disorders which may affect cerebral func- 
tion or development such as chromosomal or metabolic  
Only 7 MRI studies utilised contrast enhancement; 
Gadolinium was used in each of these [55-57,60-62,65]. 
Both MRS studies [67,72] used shimming techniques and 
water suppression chemical shift selection pulses but 
only one study discussed the additional use of Stimulated 
Echo Acquisition Mode (STEAM) [72]. 
None of the 29 included papers investigated the effect 
of using different MR magnetic field strengths on the 
appearance of brain changes caused by ID, with 11/29 of 
the studies not clarifying the strength used. Most studies 
used a 1.5 Tesla magnet strength (6/29 studies) with two 
sing a low 0.2 Tesla strength [54,70]. The animal study  u 
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Table 2. Study quality and risk of bias. 
Referen-ce Patients blinded 
Data 
collectors 
blinded
Outcome  
assesors  
blinded 
Gender 
balance
Random 
selection
Sample  
representative 
according to the 
aim of the study
Tests are 
repeatable
Results  
can be  
replicated 
Withdrawals 
from the  
study  
explained 
Inclusion/ 
exclusion criteria 
given 
Agrawal 
201166    1 F n/a ✓   n/a 
n/a  
(case report) 
Aijing 201052 ✓  (retrospective)   n/s 
all cases 
presented 
on a centre
✓ ✓  n/a ✓ 
Akinci 200667    n/s n/s ✓ ✓ ✓ n/a ✓ 
Alves 198968    1 F n/a  ✓  n/a n/a  (case report) 
Ashley 200553    1 F n/a  ✓  n/a n/a  (case report) 
Atchison 
198965    
2 F
1 M n/s ✓ ✓  n/a 
(inclusion only)
3 case reports
Blasi 200969   ✓ 10 F5 M
all (those 
consented) 
identified 
by neonatal 
screening
✓ ✓ ✓ n/a ✓ 
Dedov 199454 ✓ (retrospective)   n/s 
Included all presented 
patients (110), given the 
inclusion criteria 
✓  n/a ✓ 
Desai 199670    5 F5 M n/s  ✓  n/s  
Dutta 201264    1 M     n/a n/a (case report)
Ehirim 199855    1 M  ✓   n/a n/a (case report)
Garcia  
Centeno 
201056 
✓ 
(retrospective)   
2 M
11 F
Included all presented 
patients (56), given the 
inclusion criteria 
✓ n/a n/a ✓ 
Goswami 
199957    1M   ✓  n/a n/a (case report)
Graber 200971    1 F   ✓  n/a n/a (case report)
Gupta 200572    n/s   ✓   n/s 
Hasegawa 
201081 ✓ ✓ ✓ 
Equal 
M and 
F 
✓  ✓ ✓  ✓ 
Kroese 200458    1 F n/a  Conventional exam  n/a n/a (case report)
Lee 200859    1 F n/a  Conventional exam.  n/a n/a (case report)
Mauceri 
199773    1 M n/a ✓ 
Conventional 
exam.  n/a n/a (case report)
Fujiwara 
200874    
3 M
3 F
Screened 
all patients 
born 
2000-2004
✓ ✓  n/a ✓ 
Passeri  
201160    1 F  ✓ 
Conventional 
exam.  n/a 
n/a  
(case report) 
Sengupta 
201263    1F  ✓ ✓  n/a 
n/a  
(case report) 
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Continued 
Shogan 201061    1F     n/a n/a  (case report) 
Tai 199378    3 M     n/a n/a  (case report) 
Tajima 200775    1 M  ✓ Conventional exam.  n/a 
n/a  
(case report) 
Wheeler 
201176   ✓ 
14 M
21 F  ✓ ✓  n/a ✓ 
Wheeler 
201177   
Computational 
asessment n/s  ✓ ✓  n/a ✓ 
Young 199962    3 F  ✓ Conventional exam.  n/a 
n/a  
(case report) 
Zhu 200679    10 F1 M n/s  ✓  4 n/s 
Inclusion criteria 
only 
 
used a high strength 7 Tesla magnet [80]. Other magnet 
strengths were used by 1 study each: 0.5 Tesla [68] and 2 
Tesla [72].  
4.4. Pathologies Associated with Brain  
Abnormalities 
Several studies of ID investigated brain changes in the 
context of a particular disease, with 27/29 studying 
changes in pathological brains. In the animal study, tran- 
sient perinatal hypothyroidism was induced by anti-thy- 
roid drug methimazole and so, although mimicking the 
consequences of ID, the rat brains were considered as 
non-diseased [80]. Zhu et al. [79] reported subjects with 
subclinical hypothyroidism and so the brains of these 
individuals were considered non-pathological since they 
did not have the overt form of the disease. Brain changes 
were seen on MR in all studies in the context of certain 
pathologies: primary, non-autoimmune hypothyroidism 
(15/29 studies), congenital hypothyroidism (11/29 stud- 
ies), perinatal hypothyroidism (1/29 studies), endemic 
cretinism (1/29 study), subclinical hypothyroidism (1/29 
studies) (Figure 2).  
Primary hypothyroidism was most commonly associ- 
ated with pituitary enlargement/hyperplasia (13/15 stud- 
ies) whilst congenital hypothyroidism was related most 
strongly with cerebellar atrophy/hypoplasia (Figure 3 
and Table 3). 
4.5. Location of the Abnormalities 
Thirteen out of 29 studies (32 subjects) reported homo- 
genous diffuse enlargement of the pituitary gland and/or 
pituitary hyperplasia [52,53,55,57-63,65,66,70]. Several 
(7/29) also described suprasellar extension with com- 
pression of the optic chiasm; both features which mimic 
those of a suprasellar tumour. However, 4 other studies 
discussed empty sella turcica syndrome (i.e. absence of 
the diaphragm sella, reduced hypophysis volume and 
extension of the intrasellar subarachnoid region) [54,56,  
 
Figure 3. Studied imaged brain abnormalities in the context 
of a particular disease/pathology. This bar chart shows the 
brain abnormalities most commonly associated with par- 
ticular disease/pathologies (caused by iodine deficiency) for 
the included studies. 
 
64] and a decrease in anterior pituitary size combined 
with an ectopic posterior pituitary [74]. 
After the pituitary gland, the cerebellum was the next 
most cited location for brain abnormalities (Table 3) on 
3 case studies of congenital hypothyroid subjects [71,73, 
75], which reported abnormal cerebellar structure [71] 
and hypoplasia [71,73] or atrophy [75]. These findings 
suggest ID may contribute to aberrant development of the 
cerebellar hemispheres and vermis [73] or be associated 
with mechanisms that lead to regional atrophy [71,75]. 
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Table 3. Appearance of brain abnormalities in the context of specified diseases, on the MRI methods and sequences utilised, 
for the included studies. The number of studies that reported differently the abnormality appearance on the same disease and 
using the same MR method specified (i.e. contradictory results) is also recorded. 
Disease MR method MR sequence 
Number of studies 
using MR method 
and sequence 
Abnormality  
appearance on the MR  
method and sequence 
Number of studies reporting contradictory 
results using the same method  
(not necessarily using the same sequence) 
Decreased anterior pituitary, ectopic 
posterior pituitary74 (4/6 patients)
1 study of CH reported pituitary  
enlargement on 10/10 patients70 
No specific  
sequence stated 2 Cerebellar atrophy, intact  
brainstem and thin corpus  
callossum75 (case study) 
0 
Pituitary enlargement70  
(10/10 patients) 
1 study of CH reported decreased  
pituitary size on 4/6 patients74 
Cerebellar vermian hypoplasia, 4th 
ventricle enlargement and abnormal 
cerebellar structure71 (case study)
0 T1W 3 
Decreased L. hippocampal  
size76 (35/35 patients) 0 
Hyperintense frontal lobe  
white matter68 (case study) 0 
MRI 
T2W 2 
R. cerebellar vermis & hemisphere 
hypoplasia73 (case study) 0 
fMRI (+MRI) T1W + T2W 2 
1 study reported decreased sup. + inf. 
parietal cortex activation; increased 
SMA, precentral gyrus, insula + L 
somatosensory parietal cortex  
activation69 (15/15 patients) 
1 study reported increased bilateral activation 
in the hippocampus77 (14/14 patients), controls 
activated only left hippocampus. Not necessarily 
a contradictory result because studies’  
(refs 69 and 77) aims and tasks were different
Decreased NAA/Cr ratios in PWM + 
thalamus67 (8/8 patients) 
1 study of CH reported increased  
Cho/Cr ratio without stating any  
specific brain area on 5/5 patients72 
CH 
MRS (+MRI) T1W + T2W 2 Increased Cho/Cr ratio  
(no specific brain area stated),  
normal white matter and mild  
cortical atrophy in frontal and  
parietal lobes72 (5/5 patients) 
1study of CH reported decreased  
NAA/Cr ratios in PWM + thalamus  
on 8/8 patients67 
T2W 
 1 
Pituitary enlargement  
(1/1 patient, case study)66 
3 studies of PH reported empty sella turcica on 
20/24 patients in total54,56,64 
Pituitary enlargement52,58,62  
(Presented on 11/11 patients  
in total. Persisted in 2/11  
patients after treatment) 
 
No specific 
sequence stated, 
but figures 
showed T1W 
structural scans 
5 
Empty sella turcica54,56  
(total: 19/23 patients) 
12 studies of PH reported pituitary  
enlargement on 22/22 patients52,53,55,57-63,65,66 
Pituitary enlargement53,55,57,59,60,63,65, 66
(all case studies. Total: 10 patients)
3 studies of PH reported empty sella  
turcica on 20/24 patients in total54,56,88 
PH MRI 
T1W 12 
Sella turcica expansion with pituitary 
enlargement61 (case study) 0 
T1W 1 Hyperintense Globus pallidus + substantia nigra78 (3/3 patients) 0 
EC MRI 
T2W 1 Hypointense Globus pallidus + substantia nigra78 (3/3 patients) 0 
PerH MRI Sequence not specified 1 
Reduced total brain volume but 
ratio of hippocampal volume to 
total brain volume remains  
constant88 (8/8 animals) 
0 
SH fMRI (+MRI) T1W + T2W 1 Decreased activation in the IFG, DLPFC + SMA79 (11/11 patients) 0    
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Two studies found abnormalities in the hippocampus 
[76,80]: Wheeler et al. [76] found that the left hippo- 
campus specifically was reduced in size in 35 patients 
with congenital hypothyroidism, where as Hasegawa et 
al. [80] found that, although the hippocampal volume 
was decreased in mammals with perinatal hypothyroid- 
ism, this reduction did not affect the hippocampal to 
brain volume ratio and so was merely part of generalised 
brain atrophy. One fMRI study found increased bilateral 
activation in the hippocampus of 14/14 congenital hypo- 
thyroid patients, in contrast with 15/15 controls in which 
increased activation was only observed in the left hippo- 
campus [77] during a visuospatial memory task.  
Tai et al. [78] found that three ID patients all showed 
Sylvian fissure enlargement and abnormal signal inten- 
sity in the globus pallidus and substantia nigra on differ- 
ent MRI methods (i.e. hyperintense on T1W and hypoin- 
tense on T2W). These structures are very metabolically 
active and contain large amounts of iodine [83] and so 
may be more susceptible to insults caused by ID. Addi- 
tionally, Alves et al. [68] found hyperintense white mat- 
ter in the anterior and posterior forceps, splenium and 
frontal lobes on T2W MRI.  
The two MRS studies included obtained different re- 
sults despite studying the same disease: one found in- 
creased Cho/Cr ratio and no change in the NAA/Cr ratio 
but did not specify the brain area affected [72]; the other 
discovered decreased NAA/Cr ratios in the parietal white 
matter and thalamus and no Cho/Cr ratio abnormalities 
[67].  
Blasi et al. [69] used fMRI to show that 15 congenital  
hypothyroid patients had greater activation in the bilat- 
eral supplementary motor area, the opercular area of the 
precentral gyrus, the left somatosensory parietal cortex 
and the corresponding insula whilst control subjects had 
greater activation in the superior parietal cortex when 
performing a mental rotation task. Congenital hypothy- 
roid patients also deactivated the inferior parietal cortex 
to a greater extent than controls. Zhu et al. [79] used 
fMRI analysis on 11 patients and found that euthyroid 
patients activated five regions of interest when perform- 
ing the task but that subclinical hypothyroid subjects 
only activated 2/5 of these regions (bilateral parietal ar- 
eas and bilateral premotor areas) [79]. The blood oxygen 
level dependant response was not seen in the mid- 
dle/inferior frontal gyri, bilateral dorsolateral prefrontal 
cortex or supplementary motor area/anterior cingulate 
cortex suggesting that the frontal cortex is thus an area of 
abnormality and that working memory may be affected 
in iodine deficient subjects [79]. 
4.6. Geographical Area of the Population  
Studied in Different Studies 
Studies from 10 countries contributed data to this review: 
India (6 studies), USA (6 studies), China (4 studies), It- 
aly and Japan (Hokkaido prefecture) (3 studies each), 
Canada (2 studies) and The Netherlands, Spain, Russia 
and Turkey (1 study each) (Figure 4). From these coun- 
tries, only Italy and Russia are known to have mild to 
moderate iodine deficiency in 2011 [84] (based on me- 
dian urinary iodine level: UIC from 20 to 99 μg/L).  
 
 
Figure 4. Map showing the countries that have mild to moderate iodine deficiency based on median urinary iodine concentra- 
tion (UIC) as reported in 2011 by Anderssson et al., 2012 [84] and those from which data contributed to this review. 
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However, publications from India, Turkey and China 
refer ID as a health issue in some regions. In terms of 
sample size, the majority of the data analysed by this 
review corresponds to studies from Canada (not consid- 
ered to have ID) and from the northern region of Japan: 
known as having high iodine intake (UIC more than 300 
μg/L [84]), on a study that screened 83232 neonates, re- 
ported symptoms of ID related disease in 47 and con- 
firmed it in 6 [74].  
5. Discussion 
Iodine deficiency results in metabolic and/or structural 
brain alterations which are detectable on MR imaging 
techniques. Of the papers identified as potentially rele- 
vant, only 29/82 confirmed the presence of the brain 
changes by applying MR techniques, as the majority of 
studies in this field rely on histochemical findings as de- 
picting structural brain changes. Six studies on hypothy- 
roidism (ID related disorder) were excluded as ID was 
not explicitly stated as the cause of the disease [Exclu- 
sion criteria]. However, 3 of them use, in addition to 
MRI, a nuclear medical imaging technique: Positron 
Emission Tomography (PET) [85,86] and Single Photon 
Emission Computed Tomography (SPECT) [87]. This 
indicates that the spectrum of medical imaging tech- 
niques applied to study brain changes associated with ID 
related disorders is wide.  
Although thyroid disorders related to ID can produce 
identifiable structural brain abnormalities, these can be 
highly inconsistent (Table 3). Despite the prevalence of 
pituitary abnormalities (identified by 17/29 studies), this 
finding was highly contradictory (enlargement was re- 
ported in 32 subjects whilst size reduction or empty sella 
in 30). Cerebellar and hippocampal abnormalities were, 
however, consistently reported throughout few of the 
studies included, acknowledged by others [6,7] and 
found in animals [29,30,40,80]. Nevertheless, the major- 
ity of the studies included in this review overlooks basic 
structural brain changes (e.g. global or regional atrophy) 
and were limited to visual regional descriptions. MRI 
was used in most of the studies included in this review; 
which was dominated by research in the context of pri- 
mary and congenital hypothyroidism, both in terms of the 
number of studies and the subject sample size.  
Despite the recognized impact of ID in human health, 
the low prevalence of ID disorders in the general popula- 
tion may have incidence in the lack of large-sized studies 
evaluating structural brain changes in this condition. The 
median sample size was 5, as many of the included stud- 
ies are single case reports. Including studies which en- 
compassed iodine deficiency disorders rather than ID 
alone would have increased the scope of the review, but 
could also have meant that other non-iodine related con- 
sequences of these diseases may have affected the ap- 
pearance of the brain changes. Several of the case studies 
also often presented no methods sections and so MRI 
acquisition methods and statistical analysis methods may 
have been inadequate. With little evidence of statistical 
analysis, the significance of structural brain abnormali- 
ties/changes may have been unreliable; these brain 
structure sizes could actually be considered within the 
normal range if not compared with acceptable control 
brain scans. Additionally, representative images were 
frequently presented in these case studies, increasing 
selection bias since researchers were not blinded to case/ 
control status. 
Blasi et al. [69] and Wheeler et al. [76] were the only 
included studies from which utilised researcher blinding. 
However, these studies are inclined to create other as- 
sumptions. Blasi et al. [69] uses the siblings of the con- 
genital hypothyroid patients as control subjects, who may 
also have been affected by iodine ID in the environment 
and so may be predisposed to brain changes that have not 
yet manifested clinically or are not yet visible on MRI. 
Blasi et al. [69] additionally used fMRI along with a 
mental rotation task. The differences in blood oxygen 
level dependant response activation between cases and 
controls may be due to hypothyroid patients disengaging 
from the task rather than activating different, resultant 
brain areas [88] and there is also no guarantee in fMRI 
that subjects are performing the task as intended rather 
than thinking of other, irrelevant information, thus acti- 
vating non-task dependent brain areas. Wheeler et al. [76] 
stated that the MRI data acquired from ‘unacceptable’ 
scans was disregarded and the measurements from sub- 
jects in the same group and of the same age and gender 
were used instead. The researchers did not clarify how 
many scans were deemed inappropriate and they did not 
provide brain scan exclusion criteria specifically and so 
again, selection bias is prevalent. It also assumes that the 
disregarded scans would have been similar to those of the 
other subjects. 
Many studies were conducted to ascertain the effects 
of levothyroxine therapy in hypothyroid patients (i.e. 
whether brain abnormalities seen on MR could be re- 
versed with this treatment). Since these are not directly 
related to the effects of ID, dependability becomes more 
disputable. Other sources of inconsistency include the 
use of differing field strengths among several studies 
(ranging from 0.2T to 7T) and specific MR sequences are 
also not always provided. Pituitary hyperplasia is often 
confused with pituitary adenomas [55,62]. Hence, a con- 
sistent field strength which adequately displays these 
differences on MR images is necessary. In the study by 
Akinci et al. [67], researchers performed a whole body 
MRI scan; the clarification of small brain structure de- 
tails may have been improved by using a head coil. Sev- 
eral studies also did not detail the time-frame between 
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terms of time elapsed could increase result discrepancies. 
Tai et al. [78] discuss the brain changes found as being 
in the areas of the globus pallidus and substantia nigra; 
hyperintense on T1W and hypointense on T2W. How- 
ever, no distinction is given as to the degree of hyper- or 
hypo-intensity for which an appropriate grading scale 
consistent across all studies is required. The research in 
this paper could also have been improved by the addi- 
tional utilisation of Computed Tomography (CT) scans in 
all subjects; this would enable authors to determine whe- 
ther the change in intensity was due to calcifications and 
thus prevent assumptions. 
To the best of our knowledge, there has not been a 
systematic review before on the appearance of brain 
changes on MR caused by iodine deficiency. Despite the 
large worldwide availability of MR techniques and the 
importance of the study of iodine insufficiency, given its 
strong link with neurodevelopment and impaired cogni- 
tion, most current literature on ID reports histological 
and cytoarchitectural brain alterations only, with no MR 
confirmation. In some countries known as having mild to 
moderate ID the major causes of the disorders included 
in this review are immunological or iatrogenic rather 
than ID (e.g. United Kigdom). Therefore this review, 
rather than reflecting the spectrum of ID related brain 
abnormalities provides guidance and constitutes a call for 
future studies in ID and brain health.  
Strengths of this work include searching multiple da- 
tabases over a large time-frame, the use of comprehend- 
sive search terms, the inclusion of fMRI and MRS stud- 
ies, the inclusion of ID diseases rather than research dis- 
cussing ID alone, the inclusion of both human and ani- 
mal studies and the inclusion of healthy and diseased 
brains. A weakness, however, is the exclusion of non- 
English papers.  
The literature on brain structural and metabolic ab- 
normalities related to ID that are documented using MR 
methods is limited to few studies with differing field 
strengths and MR sequences, small sample sizes and 
poor evidence of blinding, randomisation and an inclu- 
sion/exclusion criteria in many of them. Interobserver 
bias also affects some of the included studies; for exam- 
ple, in the study by Hasegawa et al. [80] (the only in- 
cluded study that uses randomisation) volumetric analy- 
sis of the hippocampus was manually performed by one 
researcher only. Additionally, the limited description of 
the signal changes (when mentioned) lacks from an ade- 
quate (i.e. normalised) grading, all of which attempts 
against the scope of the results obtained.  
6. Directions for Future Research 
More studies are required which correlate histological 
findings with MR image results and the utilisation of 
more standardised sequences and field strengths are nec- 
essary. With the increased focus on the consequence of 
iodine insufficiency both in utero and in infancy, it is 
important to understand the brain structural modifica- 
tions caused by ID, given that neurodevelopmental and 
cognitive outcomes range in severity according to the 
level and timing of ID. Future work should include 
global and regional atrophy changes to identify directions 
for the research that will improve the understanding of 
the pathophysiological mechanisms related with the ef- 
fects of ID in the brain.  
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Acronyms and Abbreviations for Tables 
PH: Primary Hypothyroidism;  
CH: Congenital Hypothyroidism;  
EC: Endemic Cretinism;  
PerH: Perinatal Hypothyroidism;  
SH: Subclinical Hypothyroidism;  
R: right; L: left;  
NAA: N-acetylaspartate;  
Cr: Creatinine; Cho: Choline;  
sup: Superior; inf: Inferior;  
PWM Parietal White Matter;  
IFG: Inferior Frontal Gyrus;  
DLPFC: Dorsolateral Prefrontal Cortex;  
SMA: Supplementary Motor Area;  
T1W: T1-weighted sequence;  
T2W: T2-weighted sequence 
 
 
 
 
 
 
 
